Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

The rumblings on the street is the Aurinia Board had an emergency meeting on Monday to discuss the deterioration of the share price of the stock. All board members were present. They discussed all the positive analysts comments on AUPH, with targets in the range of $10-$14, no help. Four Motley Fool articles strongly recommending that AUPH is the stock to own, but still no help. The BOD fresh out of ideas pondered their predicament and finally voted on an executive order to formally require Glickman to have a professional haircut before the close of business on December 31st. They expect this will finally firm up the price of the shares going forward..